Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Organic anion transporter family (OAT family) constitutes a group of membrane transport proteins in the SLC22 solute carrier family, functioning principally to mediate the cellular transport of a wide range of endogenous and exogenous organic anions (including drugs, hormones, toxins, and metabolites) across biological membranes. OAT family members are expressed in various tissues, with a strong presence in kidneys and liver, and play crucial roles in drug elimination, metabolite excretion, and inter-organ communication. Their clinically significant broad substrate range renders them central to pharmacokinetics, drug–drug interactions, and the pathophysiology of drug toxicity and metabolic disease. However, the "OAT family" is a broad biochemical classification, and precise targeting or clinical applications require specific member identification such as OAT1 or OAT3.
Uptake/efflux of small molecule drugs and endogenous compounds (by antiport or facilitated diffusion, often exchanging organic anions with α-ketoglutarate or dicarboxylates)
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Organic anion transporter family (OAT).